Improving CLL V gamma 9V delta 2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib

Author(s):
Weerdt, I. de; Hofland, T.; Lameris, R.; Endstra, S.; Jongejan, A.; Moerland, P.D.; Bruin, R.C.G. de; Remmerswaal, E.B.M.; Berge, I.J.M. ten; Liu, N.; Stelt, M. van der; Faber, L.M.; Levin, M.D.; Eldering, E.; Tonino, S.H.; Gruijl, T.D. de; Vliet, H.J. van der; Kater, A.P.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-11-22
Language
English
Is part of
Blood (2018), Vol. 132, no. 21, p. 2260-2272
hdl
1887/94532
doi
10.1182/blood-2017-12-822569